Conecte-se

Bibliografias temáticas / Surveillance immune / Artigos de revistas

Artigos de revistas sobre o tema "Surveillance immune"

Siga este link para ver outros tipos de publicações sobre o tema: Surveillance immune.

Autor: Grafiati

Publicado: 25 de maio de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Surveillance immune".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Shastri, Nilabh, Chansu Park e Jian Guan. "Immune surveillance of immune surveillance". Molecular Immunology 150 (outubro de 2022): 2. http://dx.doi.org/10.1016/j.molimm.2022.05.018.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Swann, Jeremy B., e Mark J. Smyth. "Immune surveillance of tumors". Journal of Clinical Investigation 117, n.º 5 (1 de maio de 2007): 1137–46. http://dx.doi.org/10.1172/jci31405.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Grossman, Zvi, e Ronald B. Herberman. "‘Immune surveillance’ without immunogenicity". Immunology Today 7, n.º 5 (maio de 1986): 128–31. http://dx.doi.org/10.1016/0167-5699(86)90075-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Prehn, Richmond T., e Liisa M. Prehn. "The flip side of immune surveillance: immune dependency". Immunological Reviews 222, n.º 1 (abril de 2008): 341–56. http://dx.doi.org/10.1111/j.1600-065x.2008.00609.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Kim, Ryungsa, Manabu Emi e Kazuaki Tanabe. "Cancer immunoediting from immune surveillance to immune escape". Immunology 121, n.º 1 (maio de 2007): 1–14. http://dx.doi.org/10.1111/j.1365-2567.2007.02587.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Schaller, Julien, e Judith Agudo. "Metastatic Colonization: Escaping Immune Surveillance". Cancers 12, n.º 11 (16 de novembro de 2020): 3385. http://dx.doi.org/10.3390/cancers12113385.

Texto completo da fonte

Resumo:

Cancer immunotherapy has shifted the paradigm in cancer therapy by revitalizing immune responses against tumor cells. Specifically, in primary tumors cancer cells evolve in an immunosuppressive microenvironment, which protects them from immune attack. However, during tumor progression, some cancer cells leave the protective tumor mass, disseminating and seeding secondary organs. These initial disseminated tumor cells (DTCs) should potentially be susceptible to recognition by the immune system in the new host tissues. Although Natural Killer or T cells eliminate some of these DTCs, a fraction escape anti-tumor immunity and survive, thus giving rise to metastatic colonization. How DTCs interact with immune cells and the underpinnings that regulate imperfect immune responses during tumor dissemination remain poorly understood. Uncovering such mechanisms of immune evasion may contribute to the development of immunotherapy specifically targeting DTCs. Here we review current knowledge about systemic and site-specific immune-cancer crosstalk in the early steps of metastasis formation. Moreover, we highlight how conventional cancer therapies can shape the pre-metastatic niche enabling immune escape of newly arrived DTCs.

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Lowe, Scott. "Immune Surveillance of Senescent Cells". Innovation in Aging 5, Supplement_1 (1 de dezembro de 2021): 246. http://dx.doi.org/10.1093/geroni/igab046.952.

Texto completo da fonte

Resumo:

Abstract Cellular senescence involves a stable cell cycle arrest and a secretory program that modulates the tissue environment. In cancer, senescence acts as a potent barrier to tumorigenesis and, though many cancers evade senescence during the course of tumor evolution, ionizing radiation and conventional chemotherapy can, to varying degrees, induce senescence in tumor cells leading to potent anticancer effects. Conversely, the aberrant accumulation of senescent cells can reduce regenerative capacity and lead to tissue decline, contributing to tissue pathologies associated with age or the debilitating side-effects of cancer therapy. Our laboratory studies mechanisms of cellular senescence with the ultimate goal of developing strategies to modulate senescence for therapeutic benefit. We have focused on how senescent cells trigger immune surveillance to facilitate their own elimination or, when that fails, how synthetic immune cells (i.e. CAR T cells) can be directed to eliminate senescent cells. Recent advances in understanding senescent cell surveillance by the immune system will be discussed.

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Ahmad, Aamir. "Tumor microenvironment and immune surveillance". Microenvironment and Microecology Research 4, n.º 1 (2022): 6. http://dx.doi.org/10.53388/mmr2022006.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Oh, Julia, e Derya Unutmaz. "Immune cells for microbiota surveillance". Science 366, n.º 6464 (24 de outubro de 2019): 419–20. http://dx.doi.org/10.1126/science.aaz4014.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Zanetti, M., e N. R. Mahadevan. "Immune Surveillance from Chromosomal Chaos?" Science 337, n.º 6102 (27 de setembro de 2012): 1616–17. http://dx.doi.org/10.1126/science.1228464.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Alderton, Gemma. "Immune surveillance of the brain". Science 366, n.º 6472 (19 de dezembro de 2019): 1467.18–1469. http://dx.doi.org/10.1126/science.366.6472.1467-r.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Zinkernagel, Rolf, e Paul Klenerman. "Immune surveillance and AIDS progression". Current Biology 7, n.º 7 (julho de 1997): R403—R405. http://dx.doi.org/10.1016/s0960-9822(06)00201-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Nagarajan, Niranjana A., e Nilabh Shastri. "Immune surveillance for ERAAP dysfunction". Molecular Immunology 55, n.º 2 (setembro de 2013): 120–22. http://dx.doi.org/10.1016/j.molimm.2012.10.006.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Schmid, Dorothee, e Christian Münz. "Immune Surveillance via Self Digestion". Autophagy 3, n.º 2 (27 de março de 2007): 133–35. http://dx.doi.org/10.4161/auto.3591.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Branch, Pauline, David C. Bicknell, Andrew Rowan, Walter F. Bodmer e Peter Karran. "Immune surveillance in colorectal carcinoma". Nature Genetics 9, n.º 3 (março de 1995): 231–32. http://dx.doi.org/10.1038/ng0395-231.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Jenne, Craig N., e Paul Kubes. "Immune surveillance by the liver". Nature Immunology 14, n.º 10 (18 de setembro de 2013): 996–1006. http://dx.doi.org/10.1038/ni.2691.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Zanetti, Maurizio. "Chromosomal chaos silences immune surveillance". Science 355, n.º 6322 (19 de janeiro de 2017): 249–50. http://dx.doi.org/10.1126/science.aam5331.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Ferrone, S. "Melanoma, immune surveillance, and immunotherapy." Journal of Clinical Investigation 93, n.º 4 (1 de abril de 1994): 1351–52. http://dx.doi.org/10.1172/jci117108.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Damhofer, Helene, e Kristian Helin. "EZH2i unlocks PDAC immune surveillance". Nature Cancer 4, n.º 6 (27 de junho de 2023): 781–83. http://dx.doi.org/10.1038/s43018-023-00562-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Caruso, Roberta, e Grace Y. Chen. "High fat stems tumor immune surveillance". Cell Reports Medicine 2, n.º 12 (dezembro de 2021): 100483. http://dx.doi.org/10.1016/j.xcrm.2021.100483.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Oluwadara, Oluwadayo O., Andre Barkhordarian, Luca Giacomelli, Xenia Brant e Francesco Chiappelli. "Immune surveillance of nasopharyngeal carcinoma (NpC)". Bioinformation 7, n.º 5 (31 de outubro de 2011): 271–75. http://dx.doi.org/10.6026/97320630007271.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Jobim, Mariana, e Luiz F. J. Jobim. "Natural killer cells and immune surveillance". Jornal de Pediatria 84, n.º 7 (29 de setembro de 2008): 58–67. http://dx.doi.org/10.2223/jped.1780.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Monzavi-Karbassi, Behjatolah, Anastas Pashov e Thomas Kieber-Emmons. "Tumor-Associated Glycans and Immune Surveillance". Vaccines 1, n.º 2 (17 de junho de 2013): 174–203. http://dx.doi.org/10.3390/vaccines1020174.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Shin, Hwain, Manuela Mally, Marina Kuhn, Cecile Paroz e Guy R. Cornelis. "Escape from Immune Surveillance byCapnocytophaga canimorsus". Journal of Infectious Diseases 195, n.º 3 (fevereiro de 2007): 375–86. http://dx.doi.org/10.1086/510243.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Gruenbacher, Georg, e Martin Thurnher. "Mevalonate metabolism governs cancer immune surveillance". OncoImmunology 6, n.º 10 (27 de julho de 2017): e1342917. http://dx.doi.org/10.1080/2162402x.2017.1342917.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Eiselein, M. W. Biggs and J. E. "Suppression of immune surveillance in melanoma". Medical Hypotheses 56, n.º 6 (junho de 2001): 648–52. http://dx.doi.org/10.1054/mehy.2000.1211.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Smyth, Mark J., Ilia Voskoboinik e Joseph A. Trapani. "Immune surveillance of lymphoma in humans?" Blood 105, n.º 11 (1 de junho de 2005): 4159–60. http://dx.doi.org/10.1182/blood-2005-03-1019.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

den Hartog, Gerco, Rob van Binnendijk, Anne-Marie Buisman, Guy A. M. Berbers e Fiona R. M. van der Klis. "Immune surveillance for vaccine-preventable diseases". Expert Review of Vaccines 19, n.º 4 (29 de março de 2020): 327–39. http://dx.doi.org/10.1080/14760584.2020.1745071.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Agranovich, Alexandra, Tal Vider-Shalit e Yoram Louzoun. "Optimal viral immune surveillance evasion strategies". Theoretical Population Biology 80, n.º 4 (dezembro de 2011): 233–43. http://dx.doi.org/10.1016/j.tpb.2011.08.005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Pawelec, Graham. "MHC-Unrestricted Immune Surveillance of Leukemia1". Cancer Biotherapy 9, n.º 3 (janeiro de 1994): 265–88. http://dx.doi.org/10.1089/cbr.1994.9.265.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Starck, S. R., S. Cardinaud e N. Shastri. "Immune surveillance obstructed by viral mRNA". Proceedings of the National Academy of Sciences 105, n.º 27 (1 de julho de 2008): 9135–36. http://dx.doi.org/10.1073/pnas.0804456105.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Mahasa, Khaphetsi Joseph, Rachid Ouifki, Amina Eladdadi e Lisette de Pillis. "Mathematical model of tumor–immune surveillance". Journal of Theoretical Biology 404 (setembro de 2016): 312–30. http://dx.doi.org/10.1016/j.jtbi.2016.06.012.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Newcombe, D. S. "Immune surveillance, organophosphorus exposure, and lymphomagenesis". Lancet 339, n.º 8792 (fevereiro de 1992): 539–41. http://dx.doi.org/10.1016/0140-6736(92)90349-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Chow, Melvyn T., Andreas Möller e Mark J. Smyth. "Inflammation and immune surveillance in cancer". Seminars in Cancer Biology 22, n.º 1 (fevereiro de 2012): 23–32. http://dx.doi.org/10.1016/j.semcancer.2011.12.004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Noble, Kim A. "Rheumatoid Arthritis: Immune Surveillance Gone Wild?" Journal of PeriAnesthesia Nursing 26, n.º 2 (abril de 2011): 110–15. http://dx.doi.org/10.1016/j.jopan.2011.01.008.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Kandalaft, Lana E., Gregory T. Motz, Jaikumar Duraiswamy e George Coukos. "Tumor immune surveillance and ovarian cancer". Cancer and Metastasis Reviews 30, n.º 1 (8 de fevereiro de 2011): 141–51. http://dx.doi.org/10.1007/s10555-011-9289-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Boyd, Ashleigh S., e Neil P. Rodrigues. "Stem Cells Cycle toward Immune Surveillance". Immunity 48, n.º 2 (fevereiro de 2018): 187–90. http://dx.doi.org/10.1016/j.immuni.2018.02.006.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Young, Richard A., e Timothy J. Elliott. "Stress proteins, infection, and immune surveillance". Cell 59, n.º 1 (outubro de 1989): 5–8. http://dx.doi.org/10.1016/0092-8674(89)90861-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Zimmermann, Valerie S., Fabio Benigni e Anna Mondino. "Immune surveillance and anti-tumor immune responses: an anatomical perspective". Immunology Letters 98, n.º 1 (abril de 2005): 1–8. http://dx.doi.org/10.1016/j.imlet.2004.09.005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Garcia-Lora, Angel, Ignacio Algarra e Federico Garrido. "MHC class I antigens, immune surveillance, and tumor immune escape". Journal of Cellular Physiology 195, n.º 3 (2003): 346–55. http://dx.doi.org/10.1002/jcp.10290.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Töpfer, Katrin, Stefanie Kempe, Nadja Müller, Marc Schmitz, Michael Bachmann, Marc Cartellieri, Gabriele Schackert e Achim Temme. "Tumor Evasion from T Cell Surveillance". Journal of Biomedicine and Biotechnology 2011 (2011): 1–19. http://dx.doi.org/10.1155/2011/918471.

Texto completo da fonte

Resumo:

An intact immune system is essential to prevent the development and progression of neoplastic cells in a process termed immune surveillance. During this process the innate and the adaptive immune systems closely cooperate and especially T cells play an important role to detect and eliminate tumor cells. Due to the mechanism of central tolerance the frequency of T cells displaying appropriate arranged tumor-peptide-specific-T-cell receptors is very low and their activation by professional antigen-presenting cells, such as dendritic cells, is frequently hampered by insufficient costimulation resulting in peripheral tolerance. In addition, inhibitory immune circuits can impair an efficient antitumoral response of reactive T cells. It also has been demonstrated that large tumor burden can promote a state of immunosuppression that in turn can facilitate neoplastic progression. Moreover, tumor cells, which mostly are genetically instable, can gain rescue mechanisms which further impair immune surveillance by T cells. Herein, we summarize the data on how tumor cells evade T-cell immune surveillance with the focus on solid tumors and describe approaches to improve anticancer capacity of T cells.

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Guan, Jian, Josiah David Peske, Joshua A. Taylor e Nilabh Shastri. "The nonclassical immune surveillance for ERAAP function". Current Opinion in Immunology 70 (junho de 2021): 105–11. http://dx.doi.org/10.1016/j.coi.2021.05.008.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Ousman, Shalina S., e Paul Kubes. "Immune surveillance in the central nervous system". Nature Neuroscience 15, n.º 8 (26 de julho de 2012): 1096–101. http://dx.doi.org/10.1038/nn.3161.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Prolo, P., F. Chiappelli, G. Bernard, M. Fiala, A. Ibarra, M. L. Sartori, A. Dovio e A. Angeli. "Neuroendocrine-Immune Surveillance of Osteosarcoma: Emerging Hypothesis". Journal of Dental Research 82, n.º 6 (junho de 2003): 417–21. http://dx.doi.org/10.1177/154405910308200603.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Moser, B. "Chemokines: role in inflammation and immune surveillance". Annals of the Rheumatic Diseases 63, suppl_2 (1 de novembro de 2004): ii84—ii89. http://dx.doi.org/10.1136/ard.2004.028316.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Schmid, D., e C. Münz. "Immune surveillance of intracellular pathogens via autophagy". Cell Death & Differentiation 12, S2 (25 de outubro de 2005): 1519–27. http://dx.doi.org/10.1038/sj.cdd.4401727.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Kim, Tae Hyun, e Sang Geon Kim. "Role of CXCR6 in Antitumor Immune Surveillance". Gastroenterology 156, n.º 6 (maio de 2019): 1565–68. http://dx.doi.org/10.1053/j.gastro.2019.03.032.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Di Francesco, P., F. Pica, L. Belogi, C. Croce, C. Favalli, E. Tubaro e E. Garaci. "Influence of cocaine on murine immune surveillance". Pharmacological Research 22 (setembro de 1990): 165. http://dx.doi.org/10.1016/s1043-6618(09)80208-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Feinberg, Mark B., e Angela R. McLean. "AIDS: Decline and fall of immune surveillance?" Current Biology 7, n.º 3 (março de 1997): R136—R140. http://dx.doi.org/10.1016/s0960-9822(97)70072-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Wekerle, Hartmut. "Immune reactivity and surveillance in the CNS". Journal of Neuroimmunology 38, n.º 1-2 (maio de 1992): 179. http://dx.doi.org/10.1016/0165-5728(92)90123-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!